Literature DB >> 8167201

A pilot study of a structured interview addressing sexual function in men with schizophrenia.

M A Burke1, J P McEvoy, J C Ritchie.   

Abstract

Twenty physically healthy men with schizophrenia responded to a 15-item questionnaire inquiring about their usual and their present (on medications) sexual functioning. Two summary measures of present impairment (the average of items 7-13 that detail the patients' specific complaints of impairment, and item 15, the interviewer's global judgment of impairment) were significantly correlated with each other and with the differences between usual and present reported frequencies of erection and masturbation. More severe impairment on these summary measures was significantly associated with greater biological evidence of dopamine blockade (more severe extrapyramidal side effects and higher serum prolactin levels).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8167201     DOI: 10.1016/0006-3223(94)91164-9

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  9 in total

1.  Sexual and relationship problems amongst patients with severe chronic psychoses.

Authors:  K Bhui; A Puffet; G Strathdee
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1997-11       Impact factor: 4.328

2.  A Comparative Study of Sexual Dysfunction due to Typical and Atypical Antipsychotics in Remitted Bipolar-I Disorder.

Authors:  Anil Kumar M Nagaraj; Haque S Nizamie; Sayeed Akhtar; Baxi Neeraj P Sinha; Nishant Goyal
Journal:  Indian J Psychiatry       Date:  2004-07       Impact factor: 1.759

Review 3.  Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.

Authors:  Peter M Haddad; Angelika Wieck
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Sexual problems in schizophrenia: prevalence and characteristics. A cross sectional survey.

Authors:  Ellen Wan-Yuk Harley; Jed Boardman; Tom Craig
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-08-23       Impact factor: 4.328

5.  Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study.

Authors:  Peter F Buckley; Nina R Schooler; Donald C Goff; John Hsiao; Alexander Kopelowicz; John Lauriello; Theo Manschreck; Alan J Mendelowitz; Del D Miller; Joanne B Severe; Daniel R Wilson; Donna Ames; Juan Bustillo; Jim Mintz; John M Kane
Journal:  Schizophr Bull       Date:  2014-05-27       Impact factor: 9.306

Review 6.  Management Strategies for Antipsychotic-Related Sexual Dysfunction: A Clinical Approach.

Authors:  Angel L Montejo; Rubén de Alarcón; Nieves Prieto; José Mª Acosta; Bárbara Buch; Laura Montejo
Journal:  J Clin Med       Date:  2021-01-15       Impact factor: 4.241

7.  A comparative study of sexual dysfunction involving risperidone, quetiapine, and olanzapine.

Authors:  Anil Kumar M Nagaraj; Nagesh B Pai; Satheesh Rao
Journal:  Indian J Psychiatry       Date:  2009 Oct-Dec       Impact factor: 1.759

8.  Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).

Authors:  Deanna L Kelly; Heidi J Wehring; Amber K Earl; Kelli M Sullivan; Faith B Dickerson; Stephanie Feldman; Robert P McMahon; Robert W Buchanan; Dale Warfel; William R Keller; Bernard A Fischer; Joo-Cheol Shim
Journal:  BMC Psychiatry       Date:  2013-08-22       Impact factor: 3.630

9.  Comparative study of sexual dysfunction and serum prolactin level associated with olanzapine, risperidone, and clozapine in patients with remitted schizophrenia.

Authors:  S V Sathish Kumar; Vinod Kumar Sinha
Journal:  Indian J Psychiatry       Date:  2015 Oct-Dec       Impact factor: 1.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.